DIBBS #SPE2DP-26-T-2725

Procurement of Novartis Artemether-Lumefantrine Tablets for Malaria Treatment

This procurement opportunity from the Defense Logistics Agency (DLA) seeks Artemether-Lumefantrine Tablets for malaria treatment, with Novartis Pharmaceuticals Corporation as the approved OEM. - Government Buyer: - Defense Logistics Agency (DLA), DLA Troop Support Medical Supply Chain Pharm FSA - Contracting office at 700 Robbins Avenue, Philadelphia, PA - OEM and Vendors: - Novartis Pharmaceuticals Corporation (OEM) - Products Requested: - Artemether-Lumefantrine Tablets (NSN 6505-01-573-6500) - Part Numbers: COARTEM, NDC00078-0568-45 - Quantity: 1 bottle (24 tablets per bottle) - Each tablet: 20 mg Artemether, 120 mg Lumefantrine - Minimum shelf life: 21 months at receipt (24 months total) - Storage: 20 to 25°C - Unique/Notable Requirements: - Delivery required within 20 days to Fort Carson, CO - Strict compliance with domestic sourcing laws - Cybersecurity requirements apply - Fast award process - Place of Performance/Delivery: - Fort Carson, CO (Bldg 7465 Bad Toelz Rd, 80913-4093) - DLA contracting office in Philadelphia, PA

Description

LUMEFANTRINE ARTEME (QTY: 1, NSN: 6505-01-573-6500, Purchase Request: 7016226132) Approved Sources: - CAGE: 04520, Part No: COARTEM, Company: NOVARTIS PHARMACEUTICALS CORPORATIO - CAGE: 04520, Part No: NDC00078-0568-45, Company: NOVARTIS PHARMACEUTICALS CORPORATIO

View original listing